ScreenerHero
QPTQuest PharmaTech Inc.
TSXV · CA · Healthcare · Biotechnology · questpharmatech.com
0.0200CAD-20.00%Mkt Cap: 2.46M $P/E: 0.67

Quest PharmaTech Inc., a pharmaceutical company, develops targeted cancer therapies in Canada. Its lead product is MAb AR9.6, a theranostic agent for cancer in preclinical development for pancreatic cancer. The company i…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap2.46M $
Enterprise Value3.18M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)3.64M $
Revenue/Share—
Last Price0.0200 CAD
Fiscal Year EndJan 2026
MR QuarterJan 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.67
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.13
EPS (TTM)0.03
EPS (Forward)—
52W Range
0.02000% of range0.0500
52W High0.0500 CAD
52W Low0.0200 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE18.91%
ROA18.01%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-138.90K $
CapEx (TTM)—
FCF Margin—
FCF Yield-6.36%
Net Debt717.80K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.04
Current Ratio0.03
Quick Ratio0.01
Book Value/Sh0.1560 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield67.86%
Payout Ratio0.00%
Ex-Div DateJul 21, 2005
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.13M
Float138.75M
Insiders16.88%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short3.24K
Short (prev mo.)3.01K
Technical
SMA 500.0278 (-28.1%)
SMA 2000.0345 (-42.1%)
Beta-0.31
S&P 52W Chg18.16%
Avg Vol (30d)70.11K
Avg Vol (10d)6.98K
Technical Indicators
RSI (14)43.4
MACD-0.0022
MACD Signal-0.0021
MACD Hist.-0.0000
BB Upper0.0329 CAD
BB Middle0.0238 CAD
BB Lower0.0146 CAD
BB Width76.67%
ATR (14)0.0028 CAD
Vol Ratio (20d)0.46x